These findings indicate that the biological consequences of RASD1 downregulation are cancer-type specific, and its role in tumorigenesis may be influenced by tumor-specific factors, such as genetic alterations or microenvironmental conditions. The gene discussed is RASD1; the disease is neoplasm.